Characterisation of platelet aggregation induced by PC-3 human prostate adenocarcinoma cells and inhibited by venom peptides, trigramin and rhodostomin

This publication has 37 references indexed in Scilit:

• Characterization of integrin expression and regulation on SW-480 human colon adenocarcinoma cells and the effect of rhodostomin on basal and upregulated tumor cell adhesion
  Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1994
• Enhanced Endothelial Cell Retraction Mediated by 12(S)-HETE: A Proposed Mechanism for the Role of Platelets in Tumor Cell Metastasis
  Experimental Cell Research, 1994
• Platelets and Cancer Metastasis: More Than an Epiphenomenon
  Seminars in Thrombosis and Hemostasis, 1992
• The lipoxygenase metabolite 12(S)‐hete induces a cytoskeleton‐dependent increase in surface expression of integrin α_iibβ₃ on melanoma cells
  International Journal of Cancer, 1991
• HLA-DR is a procoagulant
  Biochemical and Biophysical Research Communications, 1991
• Analysis of integrin mRNA in human and rodent tumor cells
  Biochemical and Biophysical Research Communications, 1991
• Batroxostatin, an Arg-Gly-Asp-containing peptide from Bothrops atrox, is a potent inhibitor of platelet aggregation and cell interaction with fibronectin
  Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1990
• Trigramin: primary structure and its inhibition of von Willebrand factor binding to glycoprotein IIb/IIIa complex on human platelets
  Biochemistry, 1989
• Tumor interaction with hemostasis: The rationale for the use of platelet inhibitors and anticoagulants in the treatment of cancer
  American Journal of Hematology, 1984
• Antimetastatic effects associated with platelet reduction.
  Proceedings of the National Academy of Sciences, 1968